Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Plan selection in Medicare Part D: evidence from administrative data.

Heiss F, Leive A, McFadden D, Winter J.

J Health Econ. 2013 Dec;32(6):1325-44. doi: 10.1016/j.jhealeco.2013.06.006.

2.

Suit the action to the word, the word to the action: Hypothetical choices and real decisions in Medicare Part D.

Kesternich I, Heiss F, McFadden D, Winter J.

J Health Econ. 2013 Dec;32(6):1313-24. doi: 10.1016/j.jhealeco.2012.11.006. Epub 2012 Dec 17.

3.

PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.

Cline RR, Worley MM, Schondelmeyer SW, Schommer JC, Larson TA, Uden DL, Hadsall RS.

Res Social Adm Pharm. 2010 Jun;6(2):130-42. doi: 10.1016/j.sapharm.2010.04.002.

PMID:
20511112
4.

Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Safran DG, Strollo MK, Guterman S, Li A, Rogers WH, Neuman P.

J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.

5.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
6.

Medicare Part D--the sea of choices meets the donut hole.

Flaer PJ, Dondériz A, Younis MZ.

J Health Care Finance. 2007 Fall;34(1):1-7.

PMID:
18972980
7.

The role of satisfaction and switching costs in Medicare Part D choices.

Han J, Ko DW, Urmie JM.

Res Social Adm Pharm. 2014 Mar-Apr;10(2):398-407. doi: 10.1016/j.sapharm.2013.06.010. Epub 2013 Aug 27.

PMID:
23988694
8.
9.

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?

Mott DA, Thorpe JM, Thorpe CT, Kreling DH, Gadkari AS.

Res Social Adm Pharm. 2010 Jun;6(2):90-9. doi: 10.1016/j.sapharm.2010.02.004.

10.

National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.

Kim MH, Lin J, Kreilick C.

Adv Ther. 2009 Aug;26(8):784-94. doi: 10.1007/s12325-009-0054-1. Epub 2009 Aug 18.

PMID:
19690820
11.

Medicare Part D roulette: potential implications of random assignment and plan restrictions.

Patel RA, Walberg MP, Woelfel JA, Amaral MM, Varu P.

Medicare Medicaid Res Rev. 2013 Apr 22;3(2). pii: mmrr.003.02.a01. doi: 10.5600/mmrr.003.02.a01. eCollection 2013.

12.

Medicare part D after 2 years.

Joyce GF, Goldman DP, Vogt WB, Sun E, Jena AB.

Am J Manag Care. 2009 Aug;15(8):536-44.

13.

The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs.

Zhou C, Zhang Y.

Health Aff (Millwood). 2012 Oct;31(10):2259-65. doi: 10.1377/hlthaff.2012.0087.

14.

Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.

Polinski JM, Brookhart MA, Glynn RJ, Schneeweiss S.

J Clin Psychopharmacol. 2012 Feb;32(1):3-10. doi: 10.1097/JCP.0b013e31823fb5c4.

15.

Demand for prescription drugs under non-linear pricing in Medicare Part D.

Jung K, Feldman R, McBean AM.

Int J Health Care Finance Econ. 2014 Mar;14(1):19-40. doi: 10.1007/s10754-013-9137-2. Epub 2013 Nov 9.

PMID:
24214101
16.

Adverse selection in the Medicare prescription drug program.

Riley GF, Levy JM, Montgomery MA.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1826-37. doi: 10.1377/hlthaff.28.6.1826.

17.

Problem-based learning using the online Medicare Part D Plan Finder tool.

Cutler TW, Stebbins MR, Lai E, Smith AR, Lipton HL.

Am J Pharm Educ. 2008 Jun 15;72(3):47.

18.

Digesting the doughnut hole.

Joyce GF, Zissimopoulos J, Goldman DP.

J Health Econ. 2013 Dec;32(6):1345-55. doi: 10.1016/j.jhealeco.2013.04.007. Epub 2013 May 6.

19.

The effect of benefits, premiums, and health risk on health plan choice in the Medicare program.

Atherly A, Dowd BE, Feldman R.

Health Serv Res. 2004 Aug;39(4 Pt 1):847-64.

20.

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Gilman BH, Kautter J.

Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.

Items per page

Supplemental Content

Write to the Help Desk